$0.720100
-0.03-3.99%
Last update: 8:46 AM
15 minutes delayed
Comments
Loading...
Altamira Therapeutics (NASDAQ:CYTO) Stock, Earnings Estimates, EPS, And Revenue
Altamira Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Apr 10
EPS
$-16.470
Quarterly Revenue
$284.5K
Annual Revenue
(as of Dec 31)
(as of Dec 31)
–
Analyze the earnings history of Altamira Therapeutics using advanced sorting and filters.
Data brought to you by Benzinga APIs
Altamira Therapeutics (CYTO) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
Altamira Therapeutics (CYTO) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
FAQ
When is Altamira Therapeutics (NASDAQ:CYTO) reporting earnings?
Altamira Therapeutics (CYTO) is scheduled to report earnings on September 24, 2024. The last reported earnings were for reported on April 10, 2024 for FY.
What were the latest earnings per share (EPS) for Altamira Therapeutics (NASDAQ:CYTO)?
The Actual EPS was $-16.47, which missed the estimate of $0.00.
What were Altamira Therapeutics’s (NASDAQ:CYTO) revenues?
The Actual Revenue was $284.5K, which beat the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.